Shattuck Labs (STTK) Amortization of Deferred Charges (2022 - 2026)
Shattuck Labs (STTK) posted quarterly Amortization of Deferred Charges of $132000.0 for Q1 2026, up 11.86% year-over-year from $118000.0 in Q1 2025, and little changed quarter-over-quarter from $132000.0 in Q4 2025.
Shattuck Labs (STTK) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Amortization of Deferred Charges for 5 consecutive years, with $132000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortization of Deferred Charges rose 11.86% year-over-year to $132000.0; the TTM figure through Mar 2026 stood at $520000.0 (up 16.85% YoY), while the FY2025 annual figure was $506000.0, up 18.22% from the prior year.
- Amortization of Deferred Charges was little changed at $132000.0 in Q1 2026 per STTK's latest filing, from $132000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $133000.0 in Q3 2025 and bottomed at $65000.0 in Q1 2022.
- Historically, Amortization of Deferred Charges has averaged $101882.4 across 5 years, with a median of $101000.0 in 2024.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges surged 30.77% — and 2026, when it increased 11.86%.
- Shattuck Labs' Amortization of Deferred Charges stood at $82000.0 in 2022, then climbed by 18.29% to $97000.0 in 2023, then increased by 16.49% to $113000.0 in 2024, then gained by 16.81% to $132000.0 in 2025, then changed by 0.0% to $132000.0 in 2026.
- Business Quant data shows STTK's Amortization of Deferred Charges at $132000.0 in Q1 2026, $132000.0 in Q4 2025, and $133000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132,000.00 |
| Mar 31, 2026 | 132,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 133,000.00 |
| Sep 30, 2025 | 133,000.00 |
| Jun 30, 2025 | 123,000.00 |
| Jun 30, 2025 | 123,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | 113,000.00 |
| Dec 31, 2024 | 113,000.00 |
| Sep 30, 2024 | 109,000.00 |
| Sep 30, 2024 | 109,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 101,000.00 |
| Mar 31, 2024 | 101,000.00 |
| Dec 31, 2023 | 97,000.00 |
| Dec 31, 2023 | 97,000.00 |